HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luis Rodrigo Selected Research

Infliximab (Remicade)

11/2009Infliximab maintenance therapy is associated with decreases in direct resource use in patients with luminal or fistulizing Crohn's disease.
11/2007Sustained improvement of health-related quality of life in Crohn's disease patients treated with infliximab and azathioprine for 4 years.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luis Rodrigo Research Topics

Disease

19Neoplasms (Cancer)
04/2021 - 09/2011
17Celiac Disease (Celiac Sprue)
12/2019 - 02/2002
10Infections
12/2023 - 03/2004
9Inflammation (Inflammations)
06/2021 - 07/2014
6Colorectal Neoplasms (Colorectal Cancer)
05/2021 - 09/2012
5Carcinogenesis
12/2020 - 07/2008
5Atrophy
10/2015 - 10/2002
5Crohn Disease (Crohn's Disease)
01/2012 - 05/2003
4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2021 - 12/2006
4Ischemia
10/2019 - 01/2016
4Atherosclerosis
05/2019 - 09/2017
4Hepatocellular Carcinoma (Hepatoma)
07/2014 - 07/2002
3Hypersensitivity (Allergy)
10/2023 - 02/2015
3Pain (Aches)
01/2022 - 11/2013
3Coronary Artery Disease (Coronary Atherosclerosis)
11/2018 - 09/2017
3Stroke (Strokes)
11/2017 - 01/2016
3Diabetes Mellitus
11/2017 - 01/2012
3Fibrosis (Cirrhosis)
07/2017 - 04/2002
3Obesity
06/2017 - 04/2017
3Chronic Hepatitis C
01/2017 - 07/2002
3Ulcerative Colitis
04/2015 - 12/2006
3Fibromyalgia (Fibrositis)
08/2014 - 01/2013
3Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
11/2004 - 10/2002
2Dyspepsia (Indigestion)
04/2024 - 04/2004
2COVID-19
03/2024 - 06/2021
2Diabetic Retinopathy (Retinopathy, Diabetic)
02/2022 - 09/2017
2Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
01/2022 - 08/2014
2Reperfusion Injury
10/2019 - 01/2018
2Type 2 Diabetes Mellitus (MODY)
11/2018 - 01/2016
2Myocardial Infarction
11/2017 - 01/2016
2Peripheral Nervous System Diseases (PNS Diseases)
09/2017 - 01/2016
2Peripheral Arterial Disease
09/2017 - 01/2016
2Heart Failure
08/2017 - 01/2016
2Weight Loss (Weight Reduction)
08/2017 - 06/2017
2Body Weight (Weight, Body)
06/2017 - 11/2009
2Non-alcoholic Fatty Liver Disease
06/2017 - 04/2017
2Chronic Hepatitis B
01/2015 - 07/2002
2Autoimmune Diseases (Autoimmune Disease)
05/2010 - 04/2008
2Jaundice (Icterus)
10/2006 - 08/2005
2Cholestasis
11/2004 - 10/2002
2Liver Diseases (Liver Disease)
10/2002 - 07/2002
1Abdominal Aortic Aneurysm
12/2023
1Macular Edema
02/2022
1Astigmatism
01/2022
1Cytokine Release Syndrome
06/2021

Drug/Important Bio-Agent (IBA)

10Glutens (Glutelin)IBA
01/2022 - 10/2002
7AntibodiesIBA
01/2012 - 07/2002
6Biomarkers (Surrogate Marker)IBA
11/2019 - 04/2002
5CytokinesIBA
06/2021 - 01/2013
4micaIBA
04/2013 - 03/2004
4Protein Glutamine gamma Glutamyltransferase 2IBA
01/2013 - 10/2002
3BismuthIBA
04/2024 - 10/2020
3PhytochemicalsIBA
12/2020 - 07/2019
3AntioxidantsIBA
05/2018 - 01/2017
3DNA (Deoxyribonucleic Acid)IBA
01/2018 - 03/2004
3InterferonsIBA
04/2017 - 02/2014
3ametantrone (HAQ)IBA
08/2014 - 01/2013
2Proton Pump InhibitorsIBA
12/2023 - 12/2020
2Penicillins (Penicillin)FDA Link
10/2023 - 02/2015
2CalciumIBA
02/2022 - 06/2017
2FlavonoidsIBA
06/2021 - 12/2020
2Proteins (Proteins, Gene)FDA Link
06/2021 - 07/2002
2Toll-Like Receptors (Toll-Like Receptor)IBA
06/2021 - 07/2014
2Tissue Inhibitor of Metalloproteinase-1IBA
04/2021 - 01/2012
2Metalloproteases (Metalloproteinases)IBA
04/2021 - 01/2012
2Tetracycline (Achromycin)FDA LinkGeneric
01/2021 - 10/2020
2Capsules (Microcapsules)IBA
01/2021 - 10/2020
2Matrix Metalloproteinases (MMPs)IBA
12/2020 - 01/2012
2MicroRNAs (MicroRNA)IBA
07/2019 - 08/2017
2QuercetinIBA
01/2018 - 11/2017
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2017 - 06/2016
2Sodium Glutamate (Accent)IBA
06/2017 - 04/2017
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2017 - 04/2017
2ceric oxide (cerium dioxide)IBA
06/2017 - 12/2016
2Genetic Markers (Genetic Marker)IBA
01/2017 - 01/2013
2Levofloxacin (Levaquin)FDA Link
02/2015 - 02/2013
2Adrenal Cortex Hormones (Corticosteroids)IBA
02/2014 - 11/2010
2KIR ReceptorsIBA
01/2014 - 07/2005
2LigandsIBA
04/2013 - 04/2008
2HLA-DQ8 antigenIBA
01/2013 - 02/2002
2Infliximab (Remicade)FDA Link
11/2009 - 11/2007
2Azathioprine (Imuran)FDA LinkGeneric
11/2007 - 12/2006
2BilirubinIBA
08/2005 - 11/2004
2Immunoglobulin A (IgA)IBA
06/2005 - 10/2002
2HLA-DQB1 antigen (HLA DQB1)IBA
02/2005 - 03/2004
2HLA Antigens (Human Leukocyte Antigens)IBA
02/2005 - 03/2004
2AutoantibodiesIBA
11/2004 - 07/2002
1NucleotidesIBA
03/2024
1Ligases (Synthetase)IBA
03/2024
1Anti-Bacterial Agents (Antibiotics)IBA
12/2023
1ProcalcitoninIBA
12/2023
1MagnesiumIBA
02/2022
1InflammasomesIBA
06/2021
1Metronidazole (Metric)FDA LinkGeneric
01/2021

Therapy/Procedure

19Therapeutics
01/2022 - 10/2006
8Gluten-Free Diet
11/2018 - 01/2012
3Immunotherapy
05/2021 - 01/2013
1Lasers (Laser)
01/2022
1Proton Therapy
01/2021
1Duration of Therapy
12/2020